Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

“Very profitable” Ober Scharrer heading for a sale?

Rumour has it that German ophthalmology chain Ober Scharrer will be sold in the winter. Of course, its CEO Sibylle Stauch-Eckmann couldn’t possibly comment. Nonetheless, she tells us the group now has 5% of the country’s rapidly consolidating eye-care market and a strong pipeline offering further growth.

FREE BLOG German dentistry consolidation set to take off

A gold rush for the €17.1bn German dentistry market is beginning with a new consolidation platform set to launch. All the pieces are now in place, experts say, to build big profitable businesses in Europe’s largest and most fragmented market.

Germans pull out of Aspen deal

German hospital groups Rhoen Klinikum and Fresenius Helios are no longer considering a bid for UK rival Aspen Healthcare, say sources.

FREE BLOG Latin America – Looking beyond the ATM business model

Our inaugural Healthcare Latam conference (147 very happy delegates from 20 countries met for two days in Sao Paulo, Brazil) demonstrated the potential and the problems faced by the private health care sector in Latin America. It also revealed the future and what lay beyond the perhaps dominant fee for service business model in which many operators main aim is to max out insurance policies. Subscribers can see all presentations by going to search, clicking on type of article and choosing "presentations".

Just how close are the tech giants to muscling in on traditional insurers and operators?

Insurers and operators are worried about the threat posed by tech giants like Google, Amazon and Microsoft – and the potential for these capital rich business to muscle out traditional players with big spending and technical know-how. But is this threat really realistic?  Healthcare Nova catches up with Peter Ohnemus, CEO of Swiss health app and health score company dacadoo, to find out more.

Medicover targets Indian expansion following Q3 results

Listed pan-European healthcare and medical laboratory services provider Medicover saw its share price dip slightly, by 1.5%, as third quarter results were announced, despite a 16% jump in revenues and a 20% increase in EBITDA. India was announced as a key target for expansion, while Eastern European operations saw particularly strong growth.

Mexican pharmacy chains power into primary care

Mexico's big pharmacy chains are powering into primary care which they see as a good way to sell more prescriptions. They could already be doing as many 500,000 primary care consultations a day according to Chief Innovation Officer Carlos Perez at Proa, the largest private lab group in Mexico who was speaking at Healthcare Latam, the inaugural Pan-Latin American healthcare service event.

Find Us